A hammerhead ribozyme cleaves its target RNA during RNA preparation

Antisense and Nucleic Acid Drug Development

Volumn 6, Issue 2, 1996, Pages 141-144

  Heidenreich, Olaf ^a   Xu, Xiao ^a   Nerenberg, Michael ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; VIRUS RNA;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; RNA ANALYSIS; RNA CLEAVAGE; RNA SYNTHESIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029815359     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1996.6.141     Document Type: Article

References (13)

1. BECK, J., and NASSAL, M. (1994). Efficient hammerhead ribozyme-mediated cleavage of the structure hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res. 23, 4954-4962.
2. BOIZIAU, C., THUONG, N.T., and TOULME, J.-J. (1992). Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 89, 768-772.
3. CHOWIRA, B.M., PAVCO, P.A., and McSWIGGEN, J.A. (1994). In vitro and in vivo comparison of hammerhead, hairpin, and hepatitis Delta virus self-processing ribozyme cassettes. J. Biol. Chem. 269, 25856-25864.
4. GILMAN, M. (1994). Preparation of cytoplasmic RNA from tissue culture cells. In: Current Protocols in Molecular Biology. A. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. (John Wiley & Sons, New York), 1:1.
5. HEIDENREICH, O., BENSELER, F., FAHRENHOLZ, A., and ECKSTEIN, F. (1994). High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleosides and phosphorothioates. J. Biol. Chem. 269, 2131-2138.
6. HEIDENREICH, O., KANG, S.-H., BROWN, D.A., XU, X., SWIDERSKI, P., ROSSI, J.J., ECKSTEIN, F., and NERENBERG, M. (1995). Ribozyme-mediated RNA degradation in nucleic suspension. Nucleic Acids Res. 23, 2223-2228.
7. KARIKO, K., MEGYERI, K., XIAO, Q., and BARNATHAN, E.S. (1994). Lipofectin-aided delivery of ribozyme targeted to human urokinase receptor mRNA. FEBS Lett. 352, 41-44.
8. KIEHNTOPF, M., BRACH, M.A., LICHT, T., PETSCHAUER, S., KARAWAJEW, L., KIRSCHNING, C., and HERRMANN, F. (1994). Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J. 13, 4645-4652.
9. LANGE, W., CANTIN, E.M., FINKE, J., and DÖLKEN, G. (1993). In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA. Leukemia 7, 1786-1794.
10. LEOPOLD, L.H., SHORE, S.K., NEWKIRK, T.A., REDDY, R.M.V., and REDDY, E.P. (1995). Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias. Blood 85, 2162.
11. MARSCHALL, P., THOMSON, J.B., and ECKSTEIN, F. (1994). Inhibition of gene expression with ribozymes. Cell Mol. Neurobiol. 14, 523-538.
12. SIOUD, M., NATVIG, J.B., and FØRRE, Ø. (1992). Preformed ribozyme destroys tumour necrosis factor mRNA in human cells. J. Mol. Biol. 223, 831-835.
13. ZABNER, J., FASSENDER, A.J., MONINGER, T., POELLINGER, K.A., and WELSH, M.J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270, 18997-19007.